Sandbox vidit3: Difference between revisions
No edit summary |
No edit summary |
||
Line 60: | Line 60: | ||
{{Family tree|border=0| | A11 | | | | | A12 | | | | | A13 | | A11= | {{Family tree|border=0| | A11 | | | | | A12 | | | | | A13 | | A11= | ||
<div class="mw-customtoggle-box11" style="cursor: pointer; border-radius: 5px 5px 5px 5px; text-align: center; border: solid 1px #696969; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); background: #4682B4; width: 200%;"> | <div class="mw-customtoggle-box11" style="cursor: pointer; border-radius: 5px 5px 5px 5px; text-align: center; border: solid 1px #696969; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); background: #4682B4; width: 200%;"> | ||
{{fontcolor|#F8F8FF|'''Known etiology''' <br> Cardiovascular <br> Orthostatic hypotension <br> Reflex}} | {{fontcolor|#F8F8FF|'''Known etiology''' <br>❑ Cardiovascular <br>❑ Orthostatic hypotension <br>❑ Reflex}} | ||
</div> | </div> | ||
|A12= | |A12= | ||
Line 103: | Line 103: | ||
|A21= | |A21= | ||
<div class="mw-customtoggle-box21" style="cursor: pointer; border-radius: 5px 5px 5px 5px; text-align: center; border: solid 1px #696969; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); background: #4682B4; width: 200%;"> | <div class="mw-customtoggle-box21" style="cursor: pointer; border-radius: 5px 5px 5px 5px; text-align: center; border: solid 1px #696969; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); background: #4682B4; width: 200%;"> | ||
{{fontcolor|#F8F8FF|Was it in high risk setting? <br> Potential risk of physical injury <br> Occupational implications }} | {{fontcolor|#F8F8FF|Was it in high risk setting? <br>❑ Potential risk of physical injury <br>❑ Occupational implications }} | ||
</div>|border=0}} | </div>|border=0}} | ||
{{Family tree | | | | | | | |,|-|-|^|-|-|.| | | |,|-|^|-|.| | | }} | {{Family tree | | | | | | | |,|-|-|^|-|-|.| | | |,|-|^|-|.| | | }} | ||
Line 134: | Line 134: | ||
<div class="mw-collapsible mw-collapsed" id="mw-customcollapsible-box1" style="background: #B8B8B8; padding: 5px 10px;"> | <div class="mw-collapsible mw-collapsed" id="mw-customcollapsible-box1" style="background: #B8B8B8; padding: 5px 10px;"> | ||
'''Characterize symptoms'''<br> | |||
❑ [[Loss of consciousness]] (LOC) | |||
:❑ Rapid or slow onset | |||
:❑ Short or long duration | |||
:❑ Spontaneous complete recovery or incomplete recovery | |||
❑ [[Prodrome]]: | |||
: ❑ [[Diaphoresis]] | |||
: ❑ [[Nausea]] | |||
: ❑ [[Lightheadedness]] | |||
: ❑ [[Pallor]] | |||
: ❑ Warmth | |||
: ❑ [[Blurry vision]]<br> | |||
❑ [[Chest pain]] (suggestive of cardiovascular [[syncope]]) <br> | |||
❑ [[Palpitations]] <br> | |||
❑ Position prior to [[LOC]]: | |||
:❑ [[Supine]] (suggestive of cardiovascular [[syncope]]) | |||
:❑ [[Supine]] to erect posture (suggestive of [[orthostatic hypotension]] or reflex [[syncope]]) | |||
:❑ Prolonged standing (suggestive of reflex [[syncope]])<br> | |||
❑ Activity prior to [[LOC]]: (suggestive of cardiovascular or reflex [[syncope]]) | |||
: ❑ Driving | |||
: ❑ Machine operation | |||
: ❑ Flying | |||
: ❑ Competitive athletics <br> | |||
❑ Bowel or bladder [[incontinence]] (suggestive of reflex syncope) | |||
</div> | </div> |
Revision as of 15:50, 26 March 2014
New
Click on boxes to expand/collapse detailed information.
|
❑ Prodrome:
❑ Chest pain (suggestive of cardiovascular syncope)
❑ Activity prior to LOC: (suggestive of cardiovascular or reflex syncope)
❑ Bowel or bladder incontinence (suggestive of reflex syncope) |
Drug | Adult dosage |
---|---|
Inhaled Short Acting β Agonists (SABA) | |
Albuterol/Bitolterol/Pirbuterol a) Nebulizer solution b) MDI | ♦ 2.5-5 mg every 20 minutes for 3 doses, then 2.5-10 mg every 1-4 hours as needed or 10-15 mg/hour continuously. ♦ 4-8 puffs every 20 mins upto 4 hours, then every 1-4 hours as needed. |
Levalbuterol a) Nebulizer solution b) MDI | ♦ 1.25-2.5 mg every 20 mins for 3 doses, then 1.25-5 mg every 1-4 hours as needed. ♦ 4-8 puffs every 20 mins upto 4 hours, then every 1-4 hours as needed. |
Anticholinergics | |
Ipratropium bromide a) Nebulizer solution b) MDI | ♦ 0.5 mg every 20 mins for 3 doses, then as needed. ♦ 8 puffs every 20 mins as needed for upto 3 hours. |
Ipratropium with albuterol a) Nebulizer solution (each 3 ml containing 0.5 mg ipratropium and 2.5 mg albuterol) b) MDI (each puff contains 18 mcg ipratropium and 90 mcg albuterol) | ♦ 3 ml every 20 mins for 3 doses, then as needed. ♦ 8 puffs every 20 mins as needed for 3 hours |
Systemic corticosteroids | |
Prednisone/Prednisolone/Methylprednisolone | ♦ 40-80 mg/day in 1 or 2 divided doses until peak expiratory flowrate (PEF) reaches 70% of personal best. |
Clinical course | Unstable |
---|---|
Physical examination | Signs of heart failure |
Functional class | IV |
6MWD | Less than 400 m |
Echocardiogram | RV Enlargement |
Hemodynamics | RAP high CI low |
BNP | Elevated/Increasing |
Treatment | Intravenous prostacyclin and/or combination treatment |
Frequency of evaluation | Q 1 to Q 3 months |
FC assessment | Every clinic visit |
6MWT | Every clinic visit |
Echocardiogram2 | Q 6 to Q 12 months/center dependent |
BNP | center dependent |
RHC | Q 6 to Q 12 months or clinical deterioration |